TLPH
Talphera, Inc.
$1.07
+0.02 (+1.90%)
At close · Jul 2
Market Cap
$55.53M
Shares
51,899,648
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.07
Open$1.05
Day$1.04–1.10
52W$0.38–1.57
Avg vol 30d219K
Short int668K · 1.3% float · 4.0d
Short vol46%
Last earningsMay 13, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+8% above
+
Price vs 50-day avg
+22% above
◦
RSI (14)
64 · neutral
+
MACD trend
positive
◦
52-week position
58% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $1 › 200d $1 — 200d above 50d
+
Institutional flow
+18% holders QoQ · +12 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
1.29% of float · ▼ -26.6% MoM · 4.0 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
46 holders — near 3-yr high, broad support
Fundamentals
Weak
−
Revenue growth
−73% Y/Y
−
EPS growth
−123% Y/Y
−
Free cash flow
$-11.4M
+
Balance sheet
net cash $531.0K
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+8% above
Bullish
Price vs 50-day avg
+22% above
Bullish
RSI (14)
64 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
58% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+18% holders QoQ · +12 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.29% of float · ▼ -26.6% MoM · 4.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $1 · 58%
52-wk high $2
vs 200-day avg +8%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TLPH
this stock
Talphera, Inc.
|
$55.53M | -6.1% | -73.1% | — | 1.3% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TLPH | +0.0% | +39.0% | -1.8% | +3.9% | -6.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.4% | +40.2% | -9.9% | +4.2% | -15.4% |